Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGI
2051
DELISTED
MoneyGram International, Inc. New
MGI
| $1.95M | ﹤0.01% |
184,300
+13,200
| +8% | +$127K |
|
2052
Simulations Plus
SLP
$371M
| $1.94M | ﹤0.01% |
38,100
+2,900
| +8% | +$125K |
|
|
GOOD
2053
Gladstone Commercial Corp
GOOD
$630M
| $1.94M | ﹤0.01% |
88,100
+7,600
| +9% | +$171K |
|
2054
Zumiez
ZUMZ
$318M
| $1.93M | ﹤0.01% |
50,600
+2,300
| +5% | +$100K |
|
|
CPRX
2055
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.92M | ﹤0.01% |
231,700
+14,300
| +7% | +$101K |
|
|
AMWD
2056
DELISTED
American Woodmark
AMWD
| $1.92M | ﹤0.01% |
39,200
+2,700
| +7% | +$155K |
|
2057
A10 Networks
ATEN
$2B
| $1.92M | ﹤0.01% |
137,500
+9,300
| +7% | +$131K |
|
2058
The GEO Group
GEO
$4.14B
| $1.92M | ﹤0.01% |
289,700
+20,100
| +7% | +$132K |
|
2059
Perdoceo Education
PRDO
$1.96B
| $1.9M | ﹤0.01% |
165,800
+11,400
| +7% | +$127K |
|
|
UHT
2060
Universal Health Realty Income Trust
UHT
$573M
| $1.9M | ﹤0.01% |
32,600
+2,200
| +7% | +$128K |
|
2061
1st Source
SRCE
$2.13B
| $1.9M | ﹤0.01% |
41,089
+2,600
| +7% | +$128K |
|
|
NPTN
2062
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.9M | ﹤0.01% |
124,600
+9,700
| +8% | +$148K |
|
2063
Ranpak Holdings
PACK
$464M
| $1.89M | ﹤0.01% |
92,700
+6,300
| +7% | +$164K |
|
2064
Interface
TILE
$2.23B
| $1.89M | ﹤0.01% |
139,600
+10,300
| +8% | +$142K |
|
2065
Clear Secure
YOU
$4.75B
| $1.89M | ﹤0.01% |
70,300
+37,600
| +115% | +$932K |
|
|
CRON
2066
Cronos Group
CRON
$1.17B
| $1.89M | ﹤0.01% |
486,600
+34,700
| +8% | +$126K |
|
2067
Unitil
UTL
$984M
| $1.89M | ﹤0.01% |
37,800
+3,000
| +9% | +$147K |
|
2068
Douglas Dynamics
PLOW
$981M
| $1.88M | ﹤0.01% |
54,400
+4,000
| +8% | +$145K |
|
|
EXK
2069
Endeavour Silver
EXK
$3.14B
| $1.88M | ﹤0.01% |
405,800
+29,400
| +8% | +$128K |
|
|
SFIX
2070
Stitch Fix
SFIX
$474M
| $1.88M | ﹤0.01% |
186,600
+36,600
| +24% | +$506K |
|
|
ACB
2071
Aurora Cannabis
ACB
$237M
| $1.88M | ﹤0.01% |
47,167
+3,500
| +8% | +$148K |
|
2072
Coherus Oncology
CHRS
$181M
| $1.88M | ﹤0.01% |
145,200
+11,300
| +8% | +$144K |
|
|
ONL
2073
Orion Office REIT
ONL
$161M
| $1.88M | ﹤0.01% |
133,900
+12,600
| +10% | +$212K |
|
2074
Aclaris Therapeutics
ACRS
$860M
| $1.87M | ﹤0.01% |
108,500
+7,500
| +7% | +$102K |
|
2075
Univest Financial
UVSP
$1.18B
| $1.86M | ﹤0.01% |
69,678
+5,100
| +8% | +$150K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.